FA
EDIT icon

Financial Avengers’s Editas Medicine EDIT Stock Holding History

Financial Avengers’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-318
Closed -$2.31K – 166
2023
Q1 		$2.31K Hold
318
– – ﹤0.01% 139
2022
Q4 		$2.82K Buy
+318
New +$3.49K ﹤0.01% 136

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Financial Avengers's EDIT Position: Q2 2023 in Review

Financial Avengers sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 318 shares — an estimated $2.31K sold.

Financial Avengers first reported a position in EDIT in Q4 2022 and held it in 2 quarters. The position peaked at $2.82K in Q4 2022. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Financial Avengers reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Financial Avengers sold 318 Editas Medicine shares in Q2 2023, an estimated $2.31K.
  • Financial Avengers first reported a position in Editas Medicine in Q4 2022 and held it in 2 quarters.
  • Financial Avengers's Editas Medicine position peaked at $2.82K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Financial Avengers's 13F filing for Q2 2023, filed 7 Aug 2023.